Ishita Drugs And Industries (BOM:524400) EPS (Basic): ₹2.60 (TTM As of Mar. 2026)


BOM:524400 Ishita Drugs And Industries Ltd BOM:524400
73 GF Score
Price ₹77.17
GF Value ₹77.99
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Ishita Drugs And Industries EPS (Basic)?

Ishita Drugs And Industries BOM:524400 +7.93% 73 EPS (Basic) is ₹2.60 as of Mar. 2026. GuruFocus rates BOM:524400 with a GF Score™ of 73/100 and a GF Value™ of ₹77.99 (Fairly Valued). The stock has 3 warning signs investors should review.

Ishita Drugs And Industries's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹0.59. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.60.

Ishita Drugs And Industries's EPS (Diluted) for the three months ended in Mar. 2026 was ₹0.59. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.60.

Ishita Drugs And Industries's EPS without NRI for the three months ended in Mar. 2026 was ₹0.59. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 2.60.

During the past 12 months, Ishita Drugs And Industries's average EPS without NRIGrowth Rate was -10.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ishita Drugs And Industries's highest 3-Year average EPS without NRI Growth Rate was 49.40% per year. The lowest was -27.60% per year. And the median was 2.25% per year.

Ishita Drugs And Industries  (BOM:524400) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ishita Drugs And Industries EPS (Basic) Related Terms

Ishita Drugs And Industries EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Ishita Drugs And Industries's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ishita Drugs And Industries EPS (Basic) Chart

Ishita Drugs And Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.69 1.93 2.50 2.90 2.60

Ishita Drugs And Industries Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.96 1.01 0.48 0.52 0.59
BOM:524400
73GF Score
Ishita Drugs And Industries Ltd BOM:524400
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ishita Drugs And Industries EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ishita Drugs And Industries's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(7.785-0)/2.994
=2.60

Ishita Drugs And Industries's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.774-0)/3.007
=0.59

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹2.60 mean?
Ishita Drugs And Industries (BOM:524400) has a EPS (Basic) of ₹2.60 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ishita Drugs And Industries and its competitors.
Is Ishita Drugs And Industries' EPS (Basic) too high?
Ishita Drugs And Industries' current EPS (Basic) is ₹2.60. Overall, Ishita Drugs And Industries has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' EPS (Basic) compare to ZTS?
Ishita Drugs And Industries' EPS (Basic) of ₹2.60 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ishita Drugs And Industries and its competitors. Ishita Drugs And Industries's current EPS (Basic) is ₹2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹77.99, compared to a current price of ₹77.17 — trading 1.1% below its estimated fair value. The current EPS (Basic) is ₹2.60. Ishita Drugs And Industries' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current EPS (Basic) is ₹2.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?

Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued. The current stock price of ₹77.17 is trading 1.1% below its estimated GF Value™ of ₹77.99. GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.

Key valuation signals for BOM:524400:

  • EPS (Basic): ₹2.60
  • GF Value™: ₹77.99 vs. price of ₹77.17 (1.1% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ishita Drugs And Industries Business Description

Address C.G. Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
73GF Score

Get the complete analysis for BOM:524400

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹77.17
Price
₹77.99
GF Value